Evidence map›Paper›PMID 36743894›Full record

ArticleFrontiers in surgery2022

Coronary artery bypass grafting vs. percutaneous coronary intervention in coronary artery disease patients with advanced chronic kidney disease: A Chinese single-center study.

Yang Li, Xuejian Hou, Xiaoyu Xu, Zhuhui Huang, Taoshuai Liu, Shijun Xu, Hongliang Rui, Jubing Zheng, Ran Dong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yang LiDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xuejian HouDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaoyu XuDepartment of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhuhui HuangDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Taoshuai LiuDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Shijun XuDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hongliang RuiDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jubing ZhengDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ran DongDepartment of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Anzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Aims to compare the contemporary and long-term outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in coronary artery disease (CAD) patients with advanced chronic kidney disease (CKD). Methods: 823 CAD patients with advanced CKD (eGFR < 30 ml/min/1.73 m Results: Multivariable Cox regression models were used and propensity score matching (PSM) was also performed. After PSM, the 30-day mortality rate in the CABG group was higher than that in the PCI group but without statistically significant (6.6% vs. 2.4%, Conclusions: Among patients with CAD and advanced CKD who underwent CABG or PCI, the all-cause mortality and MACCEs were comparable between the two groups in 30 days, 1-year and 5 years. However, CABG was only associated with a significantly lower risk for repeat revascularization compared with PCI at 5 years follow-up.

Indexed as

chronic kidney diseasecoronary artery bypass graftingcoronary heart diseasepercutaneous coronary interventionrenal insufficiency

Identifiers

PMID36743894
PMCPMC9895955
OpenAlexW4317521253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.